IL6 and breast cancer: Considering that metastatic bone lesions are prevalent in patients with advanced breast cancer, it was proposed that senescent osteoblasts (which may be induced by treatment) increase local osteoclastogenesis via SASP factor IL‐6 and nourish a pro‐metastatic niche for subsequent seeding and outgrowth of breast cancer cells [182].